BiotechTube

roxadustat

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anemia

Conditions

Anemia, Hemodialysis, Renal Impairment

Trial Timeline

Feb 15, 2010 → Jun 7, 2010

NCT ID
NCT01083888

About roxadustat

roxadustat is a phase 1 stage product being developed by Astellas Pharma for Anemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01083888. Target conditions include Anemia, Hemodialysis, Renal Impairment.

What happened to similar drugs?

20 of 20 similar drugs in Anemia were approved

Approved (20) Terminated (5) Active (0)
✅Aranesp®AmgenApproved
✅Epoetin alfa 450 IU/kg once a week + Epoetin alfa 150 IU/kg 3 times a week + Epoetin alfa 450 IU/kg once a week (QW) + Epoetin alfa 150 IU/kg 3 times a week (TIW)Johnson & JohnsonApproved
✅Epoetin AlfaJohnson & JohnsonApproved
✅Roxadustat + rHuEPOAstraZenecaApproved
✅ICL670 + Chelation + No chelationNovartisApproved
✅cera, darbepoetin, epoetin-beta + ESARocheApproved
✅methoxy polyethylene glycol-epoetin beta [Mircera]RocheApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (12)

NCT IDPhaseStatus
NCT05970172Phase 3Recruiting
NCT04408820Pre-clinicalCompleted
NCT04076943Phase 2Completed
NCT03960489Phase 1Completed
NCT02964936Phase 3Completed
NCT02965040Phase 1Completed
NCT02780726Phase 3Completed
NCT02780141Phase 3Completed
NCT02779764Phase 3Completed
NCT01630889Phase 2Completed
NCT01244763Phase 2Completed
NCT01083888Phase 1Completed

Competing Products

20 competing products in Anemia

See all competitors
ProductCompanyStageHype Score
Aranesp®AmgenApproved
43
KER-047Keros TherapeuticsPhase 2
17
LY2787106Eli LillyPhase 1
29
R744 + R744Chugai PharmaceuticalPhase 3
40
epoetin beta + placeboChugai PharmaceuticalPhase 3
40
recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
40
recombinant human erythropoietin + recombinant human erythropoietinChugai PharmaceuticalPhase 3
40
darbepoetin alfaAmgenPhase 3
40
PrasugrelDaiichi SankyoPhase 1
29
Prasugrel + PlaceboDaiichi SankyoPhase 2
35
roxadustatAstellas PharmaPhase 3
40
roxadustatAstellas PharmaPhase 3
40
Roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
40
AlefaceptAstellas PharmaPhase 1
21
RoxadustatAstellas PharmaPhase 2
35
Roxadustat + PlaceboAstellas PharmaPhase 3
40
RoxadustatAstellas PharmaPre-clinical
26
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
40
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
40
roxadustatAstellas PharmaPhase 3
40